Table 3

Dosing scheme per product used in the analysis
Agent Dosing scheme
Adalimumab 80 mg at week 0, 40 mg at week 1, then 40 mg every other week
Etanercept 50 mg twice weekly for 12 weeks, then 50 mg once weekly
Infliximab 5 mg/kg at weeks 0, 2, and 6, then every 8 weeks
Ustekinumab 45 mg at weeks 0 and 4, then every 12 weeks

Avgerinou et al.

Avgerinou et al. BMC Dermatology 2012 12:10   doi:10.1186/1471-5945-12-10

Open Data